VOLUNTEER FOR RESEARCH

tincture icon.png

Cannabidiol (CBD) for Anxiety

Clinical Trial

BAcKGROUND

This project is an FDA-approved clinical trial of a whole plant-derived, high-CBD sublingual tincture for the treatment of anxiety.

STUDY DETAILS

Participants are assessed at baseline and weekly for 4 weeks of treatment. The primary outcome measures of the study are clinical state measures related to anxiety. Additionally, participants will complete measures related to quality of life, sleep, and activity levels, and cognitive testing.

Please visit  https://clinicaltrials.gov/show/NCT02548559 for more information

RECRUITMENT INFORMATION

Individuals with moderate to severe anxiety who are interested in using a high-CBD product may be eligible.

We are currently recruiting for the double-blind phase. Please note that enrolled participants will be assigned by chance to the CBD group or the placebo group. Participants have a higher chance of being enrolled in the CBD group. The study staff and the participant will not know which group a participant is in.